Related Experiment Videos
[Minimal residual disease in leukemia]
1First Dept. of Internal Medicine, Nagoya University School of Medicine, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 1, 1991
Summary
Detecting minimal residual disease (MRD) in leukemia is now possible using polymerase chain reaction (PCR). This sensitive method identifies leukemia cells during remission, aiding treatment strategies.
Area of Science:
- Hematology
- Molecular Biology
- Oncology